MCRB Insider Trading

Insider Ownership Percentage: 5.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $68,758.79

Seres Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Seres Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Seres Therapeutics Share Price & Price History

Current Price: $0.81
Price Change: Price Increase of +0.13 (19.01%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for MCRB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Seres Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2024Eric D ShaffCEOSell2,505$0.54$1,352.70170,389View SEC Filing Icon  
11/18/2024Moltke Lisa VonInsiderSell977$0.54$527.5832,415View SEC Filing Icon  
11/18/2024Thomas DesrosierEVPSell878$0.54$474.12135,192View SEC Filing Icon  
10/28/2024Eric D ShaffCEOSell8,748$0.69$6,036.12165,082View SEC Filing Icon  
10/28/2024Moltke Lisa VonInsiderSell4,334$0.69$2,990.4630,423View SEC Filing Icon  
10/28/2024Thomas DesrosierEVPSell4,259$0.69$2,938.71133,414View SEC Filing Icon  
8/16/2024Eric D ShaffCEOSell2,518$0.84$2,115.12145,993View SEC Filing Icon  
8/16/2024Moltke Lisa VonInsiderSell973$0.84$817.3221,013View SEC Filing Icon  
8/16/2024Thomas DesrosierEVPSell873$0.84$733.32124,173View SEC Filing Icon  
8/5/2024Teresa L YoungInsiderSell24,480$1.08$26,438.4078,178View SEC Filing Icon  
5/15/2024Eric D ShaffCEOSell2,435$0.94$2,288.90140,698View SEC Filing Icon  
5/15/2024Moltke Lisa VonInsiderSell939$0.94$882.6619,017View SEC Filing Icon  
5/15/2024Thomas DesrosierEVPSell843$0.94$792.42122,390View SEC Filing Icon  
2/16/2024David ArkowitzCFOSell3,939$1.08$4,254.12182,442View SEC Filing Icon  
2/16/2024Eric D ShaffCEOSell11,549$1.08$12,472.92135,321View SEC Filing Icon  
2/16/2024Teresa L YoungInsiderSell3,374$1.08$3,643.9215,705View SEC Filing Icon  
10/30/2023David ArkowitzCFOSell4,066$1.35$5,489.10175,756View SEC Filing Icon  
10/30/2023Eric D ShaffCEOSell8,552$1.35$11,545.20115,620View SEC Filing Icon  
10/30/2023Paula CloghessyInsiderSell2,904$1.35$3,920.4045,684View SEC Filing Icon  
10/30/2023Thomas DesrosierEVPSell4,156$1.35$5,610.60113,891View SEC Filing Icon  
4/28/2023David S EgeInsiderSell7,038$5.19$36,527.2259,696View SEC Filing Icon  
10/31/2022David S EgeInsiderSell5,012$7.93$39,745.1646,734View SEC Filing Icon  
7/5/2022Health Ltp Fund Ge NutritionalMajor ShareholderBuy8,738,243$3.15$27,525,465.455,875,711View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Seres Therapeutics (NASDAQ:MCRB)

59.34% of Seres Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MCRB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Seres Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024Virtu Financial LLC58,791$56K0.0%+44.8%0.034%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,388,639$1.31M0.0%+22.5%0.816%Search for SEC Filing on Google Icon
11/15/2024State Street Corp383,248$0.36M0.0%+12.9%0.225%Search for SEC Filing on Google Icon
11/15/2024Point72 Asia Singapore Pte. Ltd.44,972$43K0.0%-64.8%0.026%Search for SEC Filing on Google Icon
11/14/2024Providence Wealth Advisors LLC98,500$93K0.1%+29.2%0.058%Search for SEC Filing on Google Icon
11/13/2024FMR LLC22,857,260$21.63M0.0%+0.6%13.430%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.748,718$0.71M0.0%+42.4%0.440%Search for SEC Filing on Google Icon
10/16/2024Vontobel Holding Ltd.394,826$0.37M0.0%N/A0.261%Search for SEC Filing on Google Icon
9/16/2024Point72 DIFC Ltd87,754$64K0.0%N/A0.058%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.127,634$92K0.0%N/A0.084%Search for SEC Filing on Google Icon
8/14/2024Point72 DIFC Ltd87,754$64K0.0%N/A0.058%Search for SEC Filing on Google Icon
8/9/2024Providence Wealth Advisors LLC76,250$58K0.0%+49.5%0.050%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers55,112$40K0.0%-61.0%0.036%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC94,510$73K0.0%N/A0.062%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD298,111$0.23M0.0%-18.0%0.197%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.6,734,821$5.21M0.0%+12.1%4.460%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets46,549$36K0.0%-19.8%0.031%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.50,102$39K0.0%N/A0.033%Search for SEC Filing on Google Icon
2/14/2024Pennant Investors LP292,300$0.41M0.1%N/A0.226%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC38,091$53K0.0%+668.6%0.029%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB1,100,000$1.54M0.0%+10.0%0.851%Search for SEC Filing on Google Icon
1/24/2024Clear Creek Financial Management LLC26,950$38K0.0%-47.6%0.021%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC52,080$73K0.0%N/A0.040%Search for SEC Filing on Google Icon
12/7/2023Hudson Bay Capital Management LP1,999,800$4.76M0.0%+127.3%1.547%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.206,838$0.49M0.0%+731.3%0.160%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.23,245$55K0.0%-64.7%0.018%Search for SEC Filing on Google Icon
11/14/2023Profund Advisors LLC155,798$0.37M0.0%+11.9%0.121%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.8,981,717$21.38M0.1%-21.2%6.949%Search for SEC Filing on Google Icon
11/13/2023Dark Forest Capital Management LP117,498$0.28M0.0%N/A0.091%Search for SEC Filing on Google Icon
11/13/2023Aigen Investment Management LP75,241$0.18M0.0%+577.1%0.058%Search for SEC Filing on Google Icon
11/13/2023FMR LLC19,230,692$45.77M0.0%+0.2%14.878%Search for SEC Filing on Google Icon
11/13/2023Rafferty Asset Management LLC936,382$2.23M0.0%+21.1%0.724%Search for SEC Filing on Google Icon
11/7/2023Quantbot Technologies LP50,400$0.12M0.0%N/A0.039%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC461,209$1.10M0.0%+24.3%0.360%Search for SEC Filing on Google Icon
10/30/2023Arete Wealth Advisors LLC24,900$59K0.0%+99.2%0.019%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC11,040$26K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/19/2023Simplicity Solutions LLC11,294$27K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/11/2023Vontobel Holding Ltd.17,000$40K0.0%-52.6%0.013%Search for SEC Filing on Google Icon
8/14/2023Great Point Partners LLC938,067$4.49M0.9%N/A0.732%Search for SEC Filing on Google Icon
8/14/2023UniSuper Management Pty Ltd415,292$1.99M0.0%N/A0.324%Search for SEC Filing on Google Icon
8/14/2023Parallax Volatility Advisers L.P.134,901$0.65M0.0%N/A0.105%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.24,881$0.12M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/11/2023Natixis99,000$0.47M0.0%N/A0.077%Search for SEC Filing on Google Icon
8/11/2023E Fund Management Co. Ltd.41,581$0.20M0.0%+206.1%0.032%Search for SEC Filing on Google Icon
8/11/2023ExodusPoint Capital Management LP594,895$2.85M0.0%N/A0.464%Search for SEC Filing on Google Icon
8/10/2023Profund Advisors LLC139,249$0.67M0.0%+210.4%0.109%Search for SEC Filing on Google Icon
8/9/2023BNP Paribas Arbitrage SNC154,663$0.74M0.0%+61.9%0.121%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.45,205$0.22M0.0%+21.5%0.035%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.46,820$0.22M0.0%+37.7%0.037%Search for SEC Filing on Google Icon
8/3/2023Jennison Associates LLC1,392,356$6.67M0.0%+109.5%1.089%Search for SEC Filing on Google Icon
8/2/2023Handelsbanken Fonder AB1,000,000$4.79M0.0%+25.0%0.782%Search for SEC Filing on Google Icon
7/31/2023LPL Financial LLC115,058$0.55M0.0%+20.3%0.090%Search for SEC Filing on Google Icon
7/31/2023Alpha DNA Investment Management LLC138,536$0.66M0.2%N/A0.108%Search for SEC Filing on Google Icon
7/28/2023Mach 1 Financial Group LLC94,961$0.46M0.1%N/A0.074%Search for SEC Filing on Google Icon
7/26/2023Janney Montgomery Scott LLC90,285$0.43M0.0%-11.7%0.071%Search for SEC Filing on Google Icon
7/25/2023Raymond James & Associates10,052$48K0.0%N/A0.008%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.35,865$0.17M0.0%+74.6%0.028%Search for SEC Filing on Google Icon
7/21/2023Creative Planning17,304$83K0.0%N/A0.014%Search for SEC Filing on Google Icon
7/19/2023Teacher Retirement System of Texas27,360$0.13M0.0%-10.9%0.021%Search for SEC Filing on Google Icon
7/18/2023Diversified Trust Co10,000$48K0.0%N/A0.008%Search for SEC Filing on Google Icon
7/17/2023Clear Creek Financial Management LLC54,200$0.26M0.0%N/A0.042%Search for SEC Filing on Google Icon
7/14/2023Aries Wealth Management18,000$86K0.0%+50.0%0.014%Search for SEC Filing on Google Icon
7/13/2023Cambridge Investment Research Advisors Inc.44,844$0.22M0.0%N/A0.035%Search for SEC Filing on Google Icon
7/10/2023AE Wealth Management LLC95,188$0.46M0.0%N/A0.074%Search for SEC Filing on Google Icon
7/7/2023Auour Investments LLC17,000$81K0.0%N/A0.013%Search for SEC Filing on Google Icon
5/16/2023Avoro Capital Advisors LLC1,295,000$7.34M0.1%N/A1.013%Search for SEC Filing on Google Icon
5/15/2023Atom Investors LP90,388$0.51M0.3%-5.4%0.071%Search for SEC Filing on Google Icon
5/12/2023Profund Advisors LLC44,859$0.25M0.0%N/A0.035%Search for SEC Filing on Google Icon
5/11/2023PFG Investments LLC20,500$0.12M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/11/2023FMR LLC18,911,458$107.23M0.0%+1.2%14.794%Search for SEC Filing on Google Icon
5/11/2023Knott David M Jr315,000$1.79M0.7%+57.4%0.246%Search for SEC Filing on Google Icon
5/11/2023E Fund Management Co. Ltd.13,585$77K0.0%-18.5%0.011%Search for SEC Filing on Google Icon
5/10/2023Oppenheimer & Co. Inc.37,111$0.21M0.0%N/A0.029%Search for SEC Filing on Google Icon
5/10/2023Simplify Asset Management Inc.550,626$3.12M0.4%N/A0.431%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.15,277,356$86.62M0.2%-15.5%11.951%Search for SEC Filing on Google Icon
5/8/2023Zurcher Kantonalbank Zurich Cantonalbank24,010$0.14M0.0%+39.0%0.019%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC110,060$0.62M0.0%-37.7%0.086%Search for SEC Filing on Google Icon
5/4/2023Mirae Asset Global Investments Co. Ltd.62,240$0.35M0.0%+16.9%0.049%Search for SEC Filing on Google Icon
5/2/2023Venturi Wealth Management LLC20,000$0.11M0.0%N/A0.016%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC43,684$0.25M0.0%+206.6%0.034%Search for SEC Filing on Google Icon
4/28/2023Janney Montgomery Scott LLC102,281$0.58M0.0%+5.5%0.080%Search for SEC Filing on Google Icon
4/28/2023Handelsbanken Fonder AB800,000$4.54M0.0%N/A0.626%Search for SEC Filing on Google Icon
4/26/2023Jennison Associates LLC664,734$3.77M0.0%-0.6%0.527%Search for SEC Filing on Google Icon
4/20/2023Hennion & Walsh Asset Management Inc.61,090$0.35M0.0%-3.3%0.048%Search for SEC Filing on Google Icon
4/18/2023Macroview Investment Management LLC5,750$33K0.1%N/A0.005%Search for SEC Filing on Google Icon
4/12/2023Vontobel Holding Ltd.20,539$0.12M0.0%N/A0.016%Search for SEC Filing on Google Icon
4/11/2023Aries Wealth Management12,000$68K0.0%+20.0%0.010%Search for SEC Filing on Google Icon
3/23/2023MetLife Investment Management LLC31,931$0.18M0.0%-17.2%0.025%Search for SEC Filing on Google Icon
2/15/2023Eversept Partners LP2,200,999$12.33M1.1%+13.7%1.767%Search for SEC Filing on Google Icon
2/13/2023Boulder Hill Capital Management LP20,200$0.11M0.1%N/A0.016%Search for SEC Filing on Google Icon
2/13/2023Knott David M Jr200,100$1.12M0.4%+81.9%0.161%Search for SEC Filing on Google Icon
2/10/2023Sit Investment Associates Inc.265,000$1.48M0.0%+33.2%0.213%Search for SEC Filing on Google Icon
2/9/2023Jennison Associates LLC668,441$3.74M0.0%N/A0.537%Search for SEC Filing on Google Icon
2/9/2023Principal Financial Group Inc.41,653$0.23M0.0%+99.5%0.033%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank239,700$1.34M0.0%+3.0%0.192%Search for SEC Filing on Google Icon
2/7/2023LPL Financial LLC92,901$0.52M0.0%-8.1%0.075%Search for SEC Filing on Google Icon
2/6/2023Los Angeles Capital Management LLC63,094$0.35M0.0%-21.8%0.051%Search for SEC Filing on Google Icon
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank17,276$97K0.0%+61.9%0.014%Search for SEC Filing on Google Icon
2/1/2023Janney Montgomery Scott LLC96,954$0.54M0.0%+14.3%0.078%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Seres Therapeutics logo
Seres Therapeutics, Inc., a microbiome therapeutics company, develop microbiome therapeutics to treat the modulation of the colonic microbiome. It develops a novel class of biological drugs that are designed to treat by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. The company's lead product candidate is VOWST, an oral microbiome therapeutic that has completed Phase III clinical trial for the treatment of recurrent Clostridioides difficile infection. Its product pipeline also includes SER-155, an investigational oral fermented microbiome therapeutic which is in Phase 1b clinical trials for the treatment of gastrointestinal infections, bacteremia, and graft versus host disease in immunocompromised patients including patients receiving allogeneic hematopoietic stem cell transplantation. In addition, the company engages in the development of SER-287 which is in Phase 2b and SER-301 that is in Phase 1b to treat ulcerative colitis. Further, it has license Agreement with NHSc Rx License GmbH for the therapeutic products based on the microbiome technology, which includes VOWST product candidate, which is developed for the treatment of CDI and recurrent CDI; and collaboration license agreement with Société des Produits Nestlé S.A. (Nestlé) for the development and commercialization of certain product candidates for the treatment and management of CDI and inflammatory bowel disease including UC and Crohn's disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
Read More on Seres Therapeutics

Today's Range

Now: $0.81
Low: $0.67
High: $0.88

50 Day Range

MA: $0.83
Low: $0.55
High: $1.16

52 Week Range

Now: $0.81
Low: $0.54
High: $2.05

Volume

12,200,605 shs

Average Volume

4,357,262 shs

Market Capitalization

$138.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.06

Who are the company insiders with the largest holdings of Seres Therapeutics?

Seres Therapeutics' top insider shareholders include:
  1. David Arkowitz (CFO)
  2. Eric D Shaff (CEO)
  3. Thomas Desrosier (EVP)
  4. Teresa L Young (Insider)
  5. David S Ege (Insider)
  6. Paula Cloghessy (Insider)
  7. Moltke Lisa Von (Insider)
Learn More about top insider investors at Seres Therapeutics.

Who are the major institutional investors of Seres Therapeutics?

Seres Therapeutics' top institutional investors include:
  1. FMR LLC — 13.43%
  2. Geode Capital Management LLC — 0.82%
  3. Charles Schwab Investment Management Inc. — 0.44%
  4. Vontobel Holding Ltd. — 0.26%
  5. State Street Corp — 0.23%
  6. Providence Wealth Advisors LLC — 0.06%
Learn More about top institutional investors of Seres Therapeutics stock.

Which major investors are selling Seres Therapeutics stock?

During the last quarter, MCRB stock was sold by these institutional investors:
  1. Point72 Asia Singapore Pte. Ltd.
During the previous year, company insiders that have sold Seres Therapeutics company stock include:
  1. David Arkowitz (CFO)
  2. Eric D Shaff (CEO)
  3. Thomas Desrosier (EVP)
  4. Teresa L Young (Insider)
  5. David S Ege (Insider)
Learn More investors selling Seres Therapeutics stock.

Which major investors are buying Seres Therapeutics stock?

In the previous quarter, MCRB stock was bought by institutional investors including:
  1. Vontobel Holding Ltd.
  2. Geode Capital Management LLC
  3. Charles Schwab Investment Management Inc.
  4. FMR LLC
  5. State Street Corp
  6. Wolverine Trading LLC
  7. Providence Wealth Advisors LLC
  8. Virtu Financial LLC